ProCE Banner Activity


ASH: Updates in Multiple Myeloma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Conference Coverage
Text Module

The American Society of Hematology (ASH) Annual Meeting and Exposition is the world's premier event in hematology—both malignant and nonmalignant. Although the ASH Annual Meeting regularly features research that is key to improving patient care, keeping up with all the advances—and knowing how and when to apply them to the management of patients—can be difficult. This conference coverage activity features audio sound bites highlighting late-breaking and important new and promising data presented at ASH in multiple myeloma, chronic lymphocytic leukemia and small lymphocytic lymphoma. In this activity, Beth Faiman, PhD, MSN, APRN-BC, AOCN, selected scientific abstracts and provides expert perspectives and insights into the clinical application of each dataset and how the dataset may impact patient care.

Physician Assistants: maximum of 1.00 hours of AAPA Category 1 CME credits Registered Nurses: 1.00 Nursing contact hours, includes 1.00 hour of pharmacology credit

Released: January 11, 2022

Expiration: January 10, 2023

No longer available for credit.



Beth Faiman


Cleveland Clinic Taussig Cancer Institute
Department of Hematology and Medical Oncology
Member, Population and Cancer Prevention Program
Case Comprehensive Cancer Center
Cleveland, Ohio


This activity is supported by educational grants from Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Karyopharm Therapeutics.

Provided by

ProCE Banner

Target Audience

Oncology NPs, PAs, and nurses

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify recent practice-changing data for major hematologic malignancies that may impact frontline management and sequencing of treatment

  • Describe strategies for identification and management of adverse events associated with therapies for hematologic malignancies, including adverse events related to combination therapies


All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose to the audience all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Dr Faiman consulting fees: BMS/Celgene, Karyopharm, Sanofi Genzyme.

None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose.

Instructions for Credit

Participants wishing to earn CE/CME credit must:

  1. Review the content in its entirety
  2. Relate the content material to the learning objectives
  3. Complete the post-test and evaluation form

Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 67%.

The estimated time to complete this activity is 1.00 hour.

Release date: January 11, 2022
Expiration date: January 10, 2023


eNewsletter with audio sound bites


The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.



Joint Accreditation Statement

Joint AccreditationIn support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

ANCC Credit Designation

Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit

AAPA Credit Designation

Joint AccreditationPracticing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until January 10, 2023. PAs should only claim credit commensurate with the extent of their participation.

PA course advisor: Jessica Garner, DMSc, PA-C, University of the Pacific, Sacramento, California

IPCE Credit Designation
IPCEThis activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.

Additional Information

Program Medium

This program has been made available online.